We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$2.78B
AUM Growth
+$230M
Cap. Flow
+$22.2M
Cap. Flow %
0.8%
Top 10 Hldgs %
66.17%
Holding
474
New
12
Increased
104
Reduced
81
Closed
29

Top Buys

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$19.2M
2
RKT icon
Rocket Companies
RKT
+$11.7M
3
DOCU
DocuSign
DOCU
+$6.11M
4
MTCH icon
Match Group
MTCH
+$5.91M
5
AKUS
Akouos Inc
AKUS
+$2.22M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$15M
2
PPLI
People Inc
PPLI
+$6.88M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.46M
4
LOW icon
Lowe's Companies
LOW
+$656K
5
BA icon
Boeing
BA
+$612K

Sector Composition

Rank Sector Weight
1 Healthcare 48.09%
2 Consumer Discretionary 11.55%
3 Communication Services 7.19%
4 Technology 6.8%
5 Utilities 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRE icon
376
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.6B
$24K ﹤0.01%
685
+2
+0.3% +$71
ALTG icon
377
Alta Equipment Group
ALTG
$197M
$23K ﹤0.01%
2,939
-9,278
-76% -$73.7K
MGY icon
378
Magnolia Oil & Gas
MGY
$5.93B
$23K ﹤0.01%
4,540
-3,185
-41% -$19.8K
PXD
379
DELISTED
Pioneer Natural Resource Co.
PXD
$23K ﹤0.01%
267
– –
CDTX
380
DELISTED
Cidara Therapeutics
CDTX
$22K ﹤0.01%
387
– –
NTNX icon
381
Nutanix
NTNX
$16B
$22K ﹤0.01%
990
– –
UNIT
382
Uniti Group
UNIT
$2.26B
$22K ﹤0.01%
2,112
– –
KRRO icon
383
Korro Bio
KRRO
$151M
$21K ﹤0.01%
22
– –
OXM icon
384
Oxford Industries
OXM
$571M
$21K ﹤0.01%
530
-370
-41% -$16.7K
BEAM icon
385
Beam Therapeutics
BEAM
$2.73B
$20K ﹤0.01%
806
– –
KNL
386
DELISTED
Knoll, Inc.
KNL
$20K ﹤0.01%
1,630
-1,150
-41% -$14.2K
WBK
387
DELISTED
Westpac Banking Corporation
WBK
$20K ﹤0.01%
1,642
– –
EDIT icon
388
Editas Medicine
EDIT
$413M
$19K ﹤0.01%
680
– –
KHC icon
389
Kraft Heinz
KHC
$31.3B
$19K ﹤0.01%
633
+4
+0.6% +$133
ENTA icon
390
Enanta Pharmaceuticals
ENTA
$378M
$18K ﹤0.01%
383
-1,208
-76% -$58.5K
MPAA icon
391
Motorcar Parts of America
MPAA
$261M
$18K ﹤0.01%
1,169
-3,692
-76% -$63.3K
OXY icon
392
Occidental Petroleum
OXY
$55.6B
$17K ﹤0.01%
1,730
– –
SRI icon
393
Stoneridge
SRI
$200M
$17K ﹤0.01%
910
-740
-45% -$15.1K
PNC icon
394
PNC Financial Services
PNC
$99.2B
$16K ﹤0.01%
149
– –
LAB icon
395
Standard BioTools
LAB
$351M
$15K ﹤0.01%
1,975
-6,235
-76% -$43K
NTLA icon
396
Intellia Therapeutics
NTLA
$1.55B
$15K ﹤0.01%
734
– –
FLXN
397
DELISTED
Flexion Therapeutics, Inc.
FLXN
$15K ﹤0.01%
1,406
-4,439
-76% -$54.4K
XRX icon
398
Xerox
XRX
$456M
$14K ﹤0.01%
744
+3
+0.4% +$53
GAP
399
The Gap Inc
GAP
$7.34B
$14K ﹤0.01%
821
– –
NTUS
400
DELISTED
Natus Medical Inc
NTUS
$14K ﹤0.01%
790
-550
-41% -$10.4K
14 15
16
17 18

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return

Bollard Group's Q3 2020 Portfolio in Review

As of Q3 2020, Bollard Group held 474 positions worth $2.78B, up 9% from $2.55B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bollard Group's Q3 2020 filing shows 12 new, 104 increased, 81 reduced and 29 closed positions. Its largest new stake was Rocket Companies: 500,000 shares worth $9.96M. The largest sale was Boston Scientific, an estimated $15M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 49% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Bollard Group's largest Q3 2020 buy was Rocket Companies: 500,000 shares worth $9.96M.
  • Bollard Group added most to DraftKings in Q3 2020, an estimated $19.2M increase.
  • Bollard Group's biggest Q3 2020 reduction was Boston Scientific, cutting an estimated $15M.
  • Bollard Group fully exited Charter Communications in Q3 2020, selling an estimated $469K.
  • Bollard Group's ten largest holdings make up 66% of its $2.78B portfolio in Q3 2020.
  • Bollard Group opened 12 new positions and closed 29 in Q3 2020.
  • Bollard Group's portfolio value rose 9% quarter-over-quarter to $2.78B.

Based on Bollard Group's 13F filing for Q3 2020, filed 12 Nov 2020.